Search

You searched for "selection"

1072 results found

Erectile dysfunction part II: treatment

1 May 2014 | | URO - Andrology
Introduction The identification of specific risk factors associated with erectile dysfunction (ED) allows patients with mild or moderate ED to undergo a series of lifestyle changes, which may provide enough improvement in the erectile function to avoid pharmacotherapies. Cessation of...

History of prostate biopsy – part 2

1 September 2018 | | URO - Basic Science Research, URO - Urologic Oncology, URO - Technology
For Part 1 of this topic is available here. The major limitations of the transrectal ultrasound (TRUS) guided prostate biopsy (PBx) protocols are the risk of profound sepsis and the risk of persistently significant false negative rates, related to the...

In conversation with Neil Harvey

21 December 2021 | URO - Core Urology
We were delighted to catch up with Neil Harvey, Chair of the BAUS Section of Trainees (BSoT) about his life as a trainee urologist and his plans for the association. Can you tell us a little bit about what led...

BAUS Annual Meeting 2024

24 June 2024 -26 June 2024
Welcome from the Honorary Secretary I am thrilled to extend a warm welcome to each and every one of you as we gear up for what promises to be an enriching and enlightening conference experience. On behalf of Mo Belal,...

Lasers in urology

3 July 2026 | | URO - Technology
1. What does LASER stand for? 2. What elements are involved and how is a LASER created? 3. The following cases involve laser surgery. Can you diagnose the pathology, identify which type of lasers can be used, and their wavelengths?...

BAUS Core Urology Course 2025

21 January 2025 -24 January 2025
This is an introductory course for trainees embarking on a career in urology. The course runs over four days (Tuesday to Friday) and consists of lectures from experts in all elements of urological practice. It provides an unrivalled opportunity to meet with experienced clinicians who can help with your development as a urologist. The course is aimed at those of ST1 - ST3 grade, or those intending to apply for training in urology in the next round of national selection.

Penile cancer: a practical approach

6 November 2020 | | URO - Urologic Oncology
Penile cancer is rare and accounts for less than 1% of all new cancer cases in males in the UK, with around 640 new cases diagnosed every year [1]. In England and Wales, the annual incidence is between 1.2 and...

Online urology teaching

4 September 2020 | | URO - Technology
The COVID-19 crisis continues to disrupt our traditional models of teaching. Urological emergencies account for 20% of all acute surgical admissions and 5-10% of general practitioner visits [1]. Currently in the UK, undergraduate teaching on urology is not compulsory. Fewer...

An update on erectile dysfunction guidelines and treatment options

1 March 2019 | | URO - Andrology, URO - Technology
Erectile dysfunction is defined as the persistent inability to attain and / or maintain an erection sufficient for sexual performance. Not only does this have a psychosocial impact, it also affects the quality of life of both the patients and...

Prostate artery embolisation

1 August 2016 | | URO - Functional / Reconstructive Urology, URO - Uroradiology
Introduction Benign prostatic hyperplasia (BPH), a common condition associated with ageing, affects 50% of those between the ages of 50 and 60 years, and as many as 90% of those older than 80 years. BPH is characterised by unregulated, benign...

Ejaculatory dysfunction: a review of current practice and guidelines

1 January 2015 | | URO - Andrology
Introduction The ejaculatory process is paramount to procreation in nature. It is a complex orchestration of physiology that results in emission of the ejaculate into the posterior urethra followed by ejection of those fluids from the urethra and orgasm. The...

Biomarkers in prostate cancer detection

1 July 2018 | | URO - Basic Science Research, URO - Urologic Oncology, URO - Technology
Prostate cancer (PCa) is the second most common cancer in men with an estimated prevalence of 1.1 million worldwide in 2012. This heterogeneous disease resulted in approximately 307,000 deaths, making it the fifth leading cause of cancer-related death in men...